RESUMO
Fatigue has become an important symptom in research and also for clinical diagnosis and follow up. Many physical illnesses, in particular chronic ones such as cancer, are highly associated with fatigue. Various questionnaires for measuring fatigue have been developed, but currently no validated questionnaire exists in French language. We selected the 'Multidimensional Fatigue Inventory' (MFI) which has been validated in its English version and then translated into French by the designers. This study describes the validation step of the French version of MFI and presents the psychometric properties of this instrument. A sample of 225 patients was divided into three groups 'Tired' (82 subjects), 'Moderately tired' (36) and 'Not tired' (107). The analysis of the structure validity found four dimensions: 'General Fatigue', 'Mental Fatigue', 'Reduced Activities' and 'Motivation'. The convergent validity showed highly significant correlation (P < 0.001) with a visual analogue scale. The French MFI has been able to distinguish patients with different fatigue levels. Cronbach's alpha measurement of the scale and the subscales are good, cronbach alpha > 0.70. The reproducibility and sensitivity to change in patients who were followed up one month later show satisfactory results. This validation study of the French version of MFI shows that this instrument is valid for clinical application and allows different dimensions of fatigue to be assessed which is of particular interest for physicians, especially for cancer carers, where fatigue assessment is an important aspect of the follow up.
Assuntos
Fadiga/diagnóstico , Doenças da Glândula Tireoide/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Coleta de Dados , Feminino , Humanos , Idioma , Masculino , Pessoa de Meia-Idade , Psicometria/métodos , Reprodutibilidade dos TestesRESUMO
Breast cancer is the most common cancer in women worldwide. Many studies have been performed worldwide to assess the effectiveness of screening in terms of reduced mortality due to breast cancer. Since the end of 1989, 10 breast cancer mass screening programs using mammography have been carried out in France under the sponsorship of the National Fund for Health Prevention, Education, and Information (FNPEIS) from the National Health Insurance of Salaried Workers (CNAMTS). These 10 campaigns, which are on a district scale, are organized according to variable methods and are assessed using a common procedure. Four groups of criteria are measured in this procedure, which investigates the impact, quality, effectiveness, and costs of screening programs. The average and extreme values of each criterion as calculated from the campaigns are presented in this paper. In order to enlighten the judgment on the French results, a comparison with the international standards in force and with the results of foreign screening programs is proposed.
Assuntos
Neoplasias da Mama/diagnóstico , Idoso , Carcinoma in Situ/diagnóstico , Custos e Análise de Custo , Feminino , França , Humanos , Mamografia/economia , Programas de Rastreamento/economia , Pessoa de Meia-IdadeRESUMO
OBJECTIVE: The purpose of this work was to comparatively assess the results of mass screening programs for breast cancer implemented in six French departments in 1986, within the scope of the National Fund for Health Prevention, Education and Information of the National Health Insurance Office of Salaried Workers. MATERIAL AND METHODS: The data collected by the screening centres were analyzed by ten assessment teams that were independent from the program promotion staff, all using the same evaluation form. A complementary population study performed in eight French districts then, allowed assessing the frequency of self-referred screening (mammography performed out of program). RESULTS: The rate of participation in screening programs, in relation to the invited population, ranged from 21 to 48%, according to the district (36% in average). This low participation was probably related to the extent of self-referred screening. In fact, 19 to 40% of women, according to the district, had previously had a screening mammographic coverage: rate was around 68% in women aged 50 to 69 years. Positive findings with mammography ranged from 4.5 to 15.8% (10.1% in average), while intervention rates ranged from 0.7 to 1.6% and detection rates from 3.8 to 6.2%. The ratio between benign tumors and cancers ranged from 0.7 to 2.1 according to the district. In order to enlighten the judgement on French results, we propose a comparison with the international standards in force. CONCLUSION: The various experiences with breast cancer screening in France show that this screening is technically feasible on the basis of existing medical structures. However, some criteria are still below the expected values, especially if compared with international standards. This result is probably accounted for by the high rate self-referred screening before age 40 in France. In these conditions, the question is whether extending breast cancer screening programs in France is an appropriate course of action.
Assuntos
Neoplasias da Mama/prevenção & controle , Mamografia , Programas de Rastreamento , Neoplasias da Mama/epidemiologia , Estudos de Coortes , Comparação Transcultural , Estudos Transversais , Coleta de Dados/estatística & dados numéricos , Feminino , França/epidemiologia , Humanos , Incidência , Mamografia/estatística & dados numéricos , Programas de Rastreamento/estatística & dados numéricos , Garantia da Qualidade dos Cuidados de Saúde/estatística & dados numéricos , Encaminhamento e Consulta/estatística & dados numéricosRESUMO
This case report deals with an insulin-dependent diabetic patient suffering peripheral adrenal insufficiency who, after 12 years of substitutive treatment exhibited resistance to mineralo- and gluco-corticoids with relapse of melanodermia and plasma ACTH levels higher than 1500 pg/ml despite increasing doses. A corticotrop macroadenoma was diagnosed by MR imaging and functional tests and confirmed by surgical excision followed by disappearance of resistance. Pre-operative functional investigation show autonomisation of the adenoma but with some partial persisting regulation. This case report draws attention to this rare either complication or association which can occur in peripheral adrenal insufficiency.
Assuntos
Doença de Addison/complicações , Neoplasias do Córtex Suprarrenal/complicações , Adenoma Adrenocortical/complicações , Doença de Addison/sangue , Neoplasias do Córtex Suprarrenal/diagnóstico , Neoplasias do Córtex Suprarrenal/patologia , Adenoma Adrenocortical/diagnóstico , Adenoma Adrenocortical/patologia , Hormônio Adrenocorticotrópico/sangue , Ritmo Circadiano , Feminino , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-IdadeRESUMO
In the framework of the National Fund for Prevention, Health Education and Information, the setting-up in France, on an experimental basis, of mass breast cancer screening programs by mammography in ten departments leads to suggest a common protocol for the evaluation of these programs, before an eventual generalization to the whole country. These programs are based on common principles: local screening based on existing medical facilities, single view mammography with double reading. However, the screening organisation is different in each department according to the target population, the screening interval, the mode of invitation, the methods for arranging double reading, etc. The purpose of this article is to report on the work of the evaluation group of the ten programs, and to propose a methodology for comparing the screening experiences in order to measure the role of the organisation methods. It gives definitions and modes of calculations for the evaluation criteria in four fields: impact, quality, efficacy and cost (with details about the feasibility of data collection) and proposes a reflection on analysis techniques in order to develop an optimum mass screening strategy.
Assuntos
Neoplasias da Mama/prevenção & controle , Mamografia , Programas de Rastreamento/organização & administração , Idoso , Protocolos Clínicos , Custos e Análise de Custo , Feminino , França/epidemiologia , Humanos , Programas de Rastreamento/economia , Pessoa de Meia-Idade , Projetos Piloto , Avaliação de Programas e Projetos de Saúde , Qualidade da Assistência à SaúdeAssuntos
Síndrome da Imunodeficiência Adquirida , Coerção , Soropositividade para HIV , Direitos Humanos , Programas Obrigatórios , Pacientes , Política Pública , Programas Voluntários , Sorodiagnóstico da AIDS , Doadores de Sangue , Direitos Civis , Confidencialidade , Busca de Comunicante , Liberdade , Educação em Saúde , Homossexualidade , Humanos , Consentimento Livre e Esclarecido , Programas de Rastreamento , Preconceito , Privacidade , Saúde Pública , Quarentena , Pesquisa , Justiça Social , Seguridade Social , Experimentação Humana TerapêuticaAssuntos
Síndrome da Imunodeficiência Adquirida , Pessoal de Saúde , Exposição Ocupacional , Assistência ao Paciente , Recusa em Tratar , Sorodiagnóstico da AIDS , Confidencialidade , Busca de Comunicante , Responsabilidade pela Informação , Humanos , Doença Iatrogênica , Programas de Rastreamento , Obrigações Morais , Enfermeiras e Enfermeiros , Política Organizacional , Pacientes , Médicos , Responsabilidade Social , Sociedades , EstereotipagemAssuntos
Síndrome da Imunodeficiência Adquirida , Defesa do Paciente , Direitos do Paciente , Sorodiagnóstico da AIDS , Códigos de Ética , Coerção , Confidencialidade , Busca de Comunicante , Responsabilidade pela Informação , Ética Médica , Ética Profissional , Soropositividade para HIV , Pessoal de Saúde , Humanos , Consentimento Livre e Esclarecido , Cooperação Internacional , Internacionalidade , Jurisprudência , Programas Obrigatórios , Programas de Rastreamento , Exposição Ocupacional , Preconceito , Privacidade , Saúde Pública , Política Pública , Recusa em Tratar , Pesquisa , Estereotipagem , Experimentação Humana Terapêutica , Revelação da Verdade , Programas VoluntáriosRESUMO
At present, we can observe an evolution in ideas about the detection of HIV seropositivity through a qualitative analysis of specialised literature on the ethical aspects of AIDS. In the case of this disease, systematic screening of the population does not correspond to epidemiological criteria: it is wasteful, troublesome and costly. Whether it is voluntary, and therefore biased, or compulsory, and therefore controversial, systematic screening seems an unlikely option. This situation has prompted many versions of target-group screening, which correspond to two options: systematic screening of known risk-groups, discriminatory, confidential and anonymous; target-group screening linked to particular circumstances: recognised as necessary by blood-donors and well-accepted by pregnant mothers. This method can be institutionalised and applied in the armed forces and in prisons,.... Lastly, we consider measures taken by different countries and organisations.
Assuntos
Síndrome da Imunodeficiência Adquirida/psicologia , Ética Médica , Soropositividade para HIV/diagnóstico , Síndrome da Imunodeficiência Adquirida/diagnóstico , Confidencialidade , Soropositividade para HIV/psicologia , Humanos , Internacionalidade , Programas Obrigatórios , Programas de Rastreamento , Preconceito , Medição de Risco , Fatores de Risco , Programas VoluntáriosRESUMO
Seven of 142 cases (5%) of Mediterranean spotted fever admitted to hospital in Marseilles in 1983 and 1984 were severe. All of them were confirmed by specific laboratory tests. The disease resembles Rocky Mountain spotted fever with purpuric exanthem, confusion, renal insufficiency, hypoxaemia, thrombocytopenia, hyponatraemia and hypocalcaemia. Two patients died. The predisposing factors for severity were old age, alcoholism, heavy smoking, respiratory insufficiency and glucose-6-phosphate dehydrogenase deficiency.
Assuntos
Febre Botonosa/fisiopatologia , Infecções por Rickettsiaceae/fisiopatologia , Adulto , Fatores Etários , Idoso , Febre Botonosa/complicações , Febre Botonosa/epidemiologia , Feminino , França , Humanos , Masculino , Pessoa de Meia-Idade , Rickettsia , RiscoRESUMO
277 patients treated by radio iodine for Graves' disease were observed during a one to twenty three years period. 24 % relapse, always during the first three years. Hypothyroidism is ineluctable : 20 % from the first year and 3,4 % more each year. Goiter increases the delay for hypothyroidism occurrence. There is no linkage between hypothyroidism and radio iodine dose. Radio iodine does not cure graves' disease but give a "non hypo-non hyper" status, before secondary hypothyroidism.